Sodium Fluoride F 18
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Sodium Fluoride F 18
- Generic name
- SODIUM FLUORIDE F-18
- Manufacturer
- SOFIE Co.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 2bbd8f48-fdf9-45cb-8305-124a03f7a52c
- SPL ID
- 31e5cd99-015b-86fa-e063-6394a90ad41b
- Version
- 8
- Effective date
- 2025-04-03
- Source export date
- 2026-09-28
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/aa96b5a2be6b394393acd0090f6948bdf99e0e8e00666f81608929c8fa83db77/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:16:12
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 203592 | derived:openfda.application_number |
| application number | ANDA203592 | openfda.application_number | |
| brand name | Sodium Fluoride F 18 | openfda.brand_name | |
| generic name | SODIUM FLUORIDE F-18 | openfda.generic_name | |
| manufacturer name | SOFIE Co. | openfda.manufacturer_name | |
| ndc | package | 49609-102-01 | openfda.package_ndc |
| ndc | product | 49609-102 | openfda.product_ndc |
| ndc11 | package | 49609010201 | derived:openfda.package_ndc |
| spl id | 31e5cd99-015b-86fa-e063-6394a90ad41b | id | |
| spl set id | 2bbd8f48-fdf9-45cb-8305-124a03f7a52c | set_id | |
| unii | 9L75099X6R | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Allergic Reactions: As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available. (5.1) . Cancer Risk: Sodium Fluoride F 18 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker (5.2) . (5) . 5.1 Allergic Reactions As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available. 5.2 Radiation Risks Sodium Fluoride F 18 Injection may increase the risk of cancer. Carcinogenic and mutagenic studies with Sodium Fluoride F18 injection have not been performed. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker [ see Dosage and Administration (2.1) ].
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems. However, the completeness of these sources is not known. No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems (6) . To report SUSPECTED ADVERSE REACTIONS, contact SOFIE Co. at 1-800-207-1865 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.